Progress in HIV reduction and prevention among injection and noninjection drug users

Natalie D. Crawford, David Vlahov

Research output: Contribution to journalReview articlepeer-review

27 Scopus citations


Substantial progress has been made in reducing HIV among injection drug users (IDUs) in the United States, despite political and social resistance that reduced resources and restricted access to services. The record for HIV prevention among noninjecting drug users is less developed, although they are more numerous than IDUs. Newer treatments for opiate and alcohol abuse can now be integrated into primary HIV care; treatment for stimulant abuse is less developed. All drug users present challenges for newer HIV prevention strategies (eg, "test and treat," nonoccupational postexposure prophylaxis and preexposure prophylaxis, contingency management, and conditional cash transfer). A comprehensive HIV prevention program that includes multicomponent multilevel approaches (ie, individual, network, structural) has been effective in HIV prevention among IDUs. Expanding these approaches to noninjecting drug users, especially those at highest risk (eg, minority men who have sex with men) and incorporating these newer approaches is a public health priority.

Original languageEnglish (US)
Pages (from-to)S84-S87
JournalJournal of Acquired Immune Deficiency Syndromes
Issue numberSUPPL. 2
StatePublished - Dec 15 2010
Externally publishedYes


  • Contingency management
  • Epidemiology
  • HIV
  • Injection drug use
  • Noninjection drug use
  • Prevention
  • Treatment

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)


Dive into the research topics of 'Progress in HIV reduction and prevention among injection and noninjection drug users'. Together they form a unique fingerprint.

Cite this